Ontology highlight
ABSTRACT:
INSTRUMENT(S):
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): T Cell, T-cell Acute Lymphoblastic Leukemia Cell
DISEASE(S): Acute Leukemia
SUBMITTER:
Zimu Zhang
LAB HEAD: Ling Xu
PROVIDER: PXD053080 | Pride | 2025-10-13
REPOSITORIES: Pride
| Action | DRS | |||
|---|---|---|---|---|
| XA06385LI_XLIgG.raw | Raw | |||
| XA06385LI_XLflagusp20.raw | Raw | |||
| XLIgG.zip | Other | |||
| XLflagusp20.zip | Other |
Items per page: 1 - 4 of 4 |

Acta pharmaceutica Sinica. B 20250705 9
T-cell acute lymphoblastic leukemia (T-ALL) is a highly aggressive hematologic malignancy with a poor prognosis, despite advancements in treatment. Many patients struggle with relapse or refractory disease. Investigating the role of the super-enhancer (SE) regulated gene ubiquitin-specific protease 20 (<i>USP20</i>) in T-ALL could enhance targeted therapies and improve clinical outcomes. Analysis of histone H3 lysine 27 acetylation (H3K27ac) chromatin immunoprecipitation sequencing (ChIP-seq) da ...[more]